Abstract:Interphotoreceptor retinoid-binding protein (IRBP) greatly enhances the conversion of all- trans -retinol to 11- cis -retinal by the retinal pigment epithelium (RPE) and facilitates 11- cis -retinal release from the RPE. However, the mechanisms by which IRBP exerts these effects are not clear. Using a model system of purified bovine IRBP and isolated bovine RPE membranes, we investigated the possibility that IRBP may favor the delivery of all- trans -retinol to, or the release of 11- cis -retinal from, RPE membranes. As the interphotoreceptor space contains serum retinol-binding protein (RBP) and serum albumin in addition to IRBP, we similarly examined the exchange of retinoids between RPE membranes and human RBP or bovine serum albumin (BSA). Isolated RPE membranes were loaded with radioactive 11- cis -retinal and incubated with solutions of IRBP, RBP, BSA or with buffer alone. Membranes (pellet) and retinoid-binding protein or buffer (supernatant) were separated by centrifugation and analysed for radioactive 11- cis -retinal. Membranes incubated with buffer alone released only 4-5% of their 11- cis -retinal, while 25 microm IRBP removed 18-35%. More retinal was released as the membrane concentration was reduced. In contrast, RBP and BSA removed little retinal, even though both proteins are capable of binding this retinoid. Similar results were obtained with bovine liver membranes, consistent with the idea that the effects of IRBP do not depend on an RPE surface receptor for IRBP. IRBP was also markedly superior to RBP and BSA in removing all- trans -retinol from RPE membranes. In addition, IRBP efficiently delivered bound all- trans -retinol to membranes; however, in contrast to their differential removal of retinoids, all three binding proteins delivered comparable amounts of retinol to membranes. (This result supports the practice of using BSA as a retinoid carrier in in vitro experimental systems). We conclude that, whereas IRBP shares with other retinoid-binding proteins the ability to deliver retinol to membranes, IRBP is unique in its capacity to remove 11- cis -retinal from membranes. This may be the feature of IRBP that drives the vitamin A cycle to efficiently produce 11- cis -retinal.

Immunological mutants of the mouse.

When Experiments Travel: Clinical Trials and the Global Search for Human Subjects Adriana Petryna, Princeton University Press, 2009

Semiparametric regression modelling of current status competing risks data: a Bayesian approach

Penalized Variable Selection with Broken Adaptive Ridge Regression for Semi-competing Risks Data

Hierarchical models for semi-competing risks data with application to quality of end-of-life care for pancreatic cancer

Maximum likelihood estimation of semiparametric mixture component models for competing risks data

Bayesian joint modeling of multivariate longitudinal and survival outcomes using Gaussian copulas

A Proportional Hazards Model for the Subdistribution of a Competing Risk

A Bayesian nonparametric approach for evaluating the causal effect of treatment in randomized trials with semi-competing risks

Modeling cure fraction with frailty term in latent risk: a Bayesian approach

Two-stage pseudo maximum likelihood estimation of semiparametric copula-based regression models for semi-competing risks data

Dependent Dirichlet Processes for Analysis of a Generalized Shared Frailty Model

[Internal validity and diagnostic utility of the Eating Disorder Inventory in Mexican women].

[Clinical and pharmacological aspects of rifaximin, local antibiotic therapy in intestinal disorders].

Analysis of dependent left-truncated and right-censored competing risks data with partially observed failure causes

Pancreatic cholesterol esterases. 3. Kinetic characterization of cholesterol ester resynthesis by the pancreatic cholesterol esterases.

Causal inference for semi-competing risks data

IRBP enhances removal of 11- cis -retinaldehyde from isolated RPE membranes.

A Simplified Stochastic EM Algorithm for Cure Rate Model with Negative Binomial Competing Risks: An Application to Breast Cancer Data

Bayesian modelling of inseparable space-time variation in disease risk

Joint Dynamic Models and Statistical Inference for Recurrent Competing Risks, Longitudinal Marker, and Health Status